MedTrace Logo

Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin

NCT00631865 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2016-07-20

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of melanocytes in patients with vitiligo.

Conditions

  • Vitiligo

Interventions

BIOLOGICAL

Melanocyte transplantation

Injection of melanocytes directly in Epidermis

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hossein Baharvand, PhD · Head of Royan stem cell department

  • Saeeid Shafieian, MD · Firoozgar Hospital

  • Nasser Aghdami, MD., PhD · Head of Royan transplantation Lab

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2015-02-28
Completion
2015-05-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00631865 on ClinicalTrials.gov